Yu dɔn ɛva tek mɛrɛsin? Ɔ dɛn bin du am ɔpreshɔn? If na so, yu no se di tritmɛnt we yu bin gɛt, dɛn bin tɛst am pan mɛrɛsin risach fɔ mek shɔ se i sef ɛn kwaliti bifo i rich na yu an? Tide wi de tɔk bɔt dis impɔtant joyn we de briŋ nyu mɛrɛsin ɛn tritmɛnt to wi. Fɔ tɔk am simpul wan, wi de tɔk bɔt mɛrɛsin stɔdi .
Wetin na mɛdikal stɔdi?
Fɔ tɔk am simpul wan, mɛdikal risach na di we aw dɛn kin tɛst nyu mɛrɛsin, ɔpreshɔn, ɔ mɛrɛsin divays pan grup dɛn. Dɛn tray ya de mek di wan dɛn we de stɔdi bɔt dis ebul fɔ no if nyu tritmɛnt nɔ bad ɛn if i rili wok .
Wi kin sheb dɛn tin ya to tu men kayn.
1. Klinik Trial dɛn
Dis na di say we dɛn kin kɔmpia nyu mɛrɛsin, divays, ɔ tritmɛnt wit sɔntin we dɔn ɔlrɛdi de. Imajin se yu dɔn fɛn wan nyu mɛrɛsin fɔ dayabitis. Na dis na aw yu de tɛst am:
- Wit di bɛst tritmɛnt we de naw: Dɛn de kɔmpia di nyu mɛrɛsin wit di bɛst tritmɛnt fɔ dayabitis naw.
- Wit plasɛbo: Dis rili impɔtant. ``Plasɛbo'' na sɔntin we tan lɛk mɛrɛsin, bɔt i nɔ rili gɛt ɛni aktif famasi ingridiɛnt. Sɔntɛnde, jɔs fɔ tink se i go mek yu fil fayn, dat kin mek yu fil fayn smɔl. So dɛn kin yuse dis fɔ no if di nyu mɛrɛsin rili de wok ɔ if na jɔs wan saykilɔjik ifɛkt we de mek yu fil fayn.
- Nɔ tritmɛnt: Sɔntɛnde, dɛn kin kɔmpia am wit grup we nɔ gɛt ɛni tritmɛnt.
Di wan dɛn we de du risach kin sheb di wan dɛn we tek pat to tu grup. Dɛn kin gi wan grup di nyu tritmɛnt. di כda grup dεn kin gi di tritmεnt we de naw כ wan ``plesεbo''. Dɔn dɛn kin kɔmpia di tin dɛn we dɛn tu grup ya dɔn du.
2. Stɔdi dɛn we dɛn kin du we dɛn de wach
Dis min se yu fɔ wach wetin kin apin to pipul dɛn we dɛn fala wan patikyula tritmɛnt ɔ layf. Fɔ ɛgzampul, fɔ stɔdi bɔt di difrɛns pan wɛlbɔdi biznɛs bitwin pipul dɛn we de du ɛksasaiz ɔltɛm ɛn di wan dɛn we nɔ de du ɛksasaiz.
Udat kam wit dɛn risach aidia ya? Udat de gi di mɔni?
Bɔku tɛm, di aidia fɔ dis kayn mɛdikal risach kɔmɔt frɔm wan risachman na ɔspitul, yunivasiti mɛdikal sɛnta, ɔ famasi kɔmni. Dɔn di pɔsin we de du di risach kin disayn di stɔdi fɔ ansa sɔm kwɛstyɔn dɛn. Fɔ ɛgzampul, “Dis drɔg bɛtɛ pas di drɔgs we dɔn de?” “I go mek pɔsin gɛt sayd ɛfɛkt ?”
Risach lɛk dis kin tek bɔku bɔku mɔni. Da mɔni de kɔmɔt frɔm:
- Frɔm kɔmni dɛn we de mek drɔgs ɔ mɛrɛsin dɛn.
- Frɔm yunivasiti mɛdikal sɛnta dɛn.
- Frɔm ɔganayzeshɔn dɛn we nɔ de du biznɛs lɛk di Alzheimer ’s Association ɔ di American Cancer Society.
- Frɔm gɔvmɛnt ɛjɛnshi dɛm lɛk di Nashɔnal Instityut fɔ Wɛlbɔdi biznɛs.
Udat mek dɛn tin ya? Usay dɛn mek dɛn?
Ɛvri risach wok na wan Prinsipal Investigator de lid am . Bɔku tɛm, da pɔsin de na dɔktɔ. Wan big grup we de du risach de ɛp am. Da tim de inklud:
- Dɔktɔ dɛn
- Nɔs dɛn
- Soshal woka dɛn
- Di wan dɛn we sabi bɔt it
- Medikal studɛnt dɛn
- Ɔda pipul dɛn we sabi bɔt wɛlbɔdi biznɛs de insay.
Dɛn kin du dis risach na ɔspitul dɛn, yunivasiti risach sɛnta dɛn, kɔmyuniti klinik dɛn, ɛn dɔktɔ dɛn ɔfis dɛn. Sɔntɛnde, di risach kin ivin pe fɔ plen, transpɔt, ɛn ɔtel ɛkspɛns fɔ pipul dɛn we de fa frɔm di risach sɛnta.
Udat dɛn de tek pat pan di risach? Wetin na di stej dɛm fɔ dis?
Na pipul dɛn we jɔs tan lɛk yu mek am. Pipul dɛn we gɛt ɔl kayn ej, difrɛn kɔlɔ, ɛn man ɔ uman de insay. Sɔm pipul kin jɔyn bikɔs ɔda tritmɛnt wae dɛn dɔn tray nɔr dɔn woke. Ɔda pipul dɛn kin jɔyn bikɔs no mɛrɛsin nɔ de fɔ dɛn sik yet.
I rili impɔtant fɔ mek bifo dɛn gi pipul dɛn nyu tritmɛnt, dɛn fɔ tɛst am fɔs pan animal dɛn we dɛn kin yuz na lɛbɔtri fɔ si if i kin mek dɛn du ɛni bad tin. Na di tritmɛnt dɛn nɔmɔ we sho se gud sef, dɛn kin transfa to klinik trial pan mɔtalman.
Fo men pat dɛn de we dɛn kin du risach bɔt mɛrɛsin. Di nɔmba fɔ di wan dɛn we tek pat kin go ɔp wit ɛni pat.
| Tɛm | Tɔk bɔt |
|---|---|
| Faz I we yu de du | Na lɛk 20-80 pipul dɛn kin tek pat. Di men gol na fɔ no if di tritmɛnt sef ɛn wetin na di kɔrɛkt doz . |
| Faz II | Na lɛk 100-300 pipul dɛn kin tek pat. Dis pat na fɔ si aw dis tritmɛnt de wok fayn fɔ wan patikyula kɔndishɔn. |
| Faz III | Bɔku bɔku pipul dɛn kin tek pat. Dɛn kin luk aw di tritmɛnt de woke pan difrɛn grup dɛm fɔ pipul dɛm, pan difrɛn dos dɛm. If di rizɔlt fɔ dis pat dɔn wok fayn, di ɛjɛnshi dɛm lɛk di US Food and Drug Administration (FDA) go gri fɔ di tritmɛnt. |
| Faz IV | Dɛn kin du dis afta dɛn dɔn gri fɔ tek di tritmɛnt. Di rizin na fɔ wach aw i sef fɔ lɔng tɛm . |
Wetin na di kwaliti dɛm fɔ gud, rilibul mɛdikal risach?
Bifo yu dɔktɔ gi yu nyu mɛrɛsin, i kin rid mɛdikal risach ripɔt dɛn lɛk dis fɔ no if i de wok ɛn i nɔ bad. Dɛn kin sho bak us sayd ɛfɛkt dɛn we wan tritmɛnt kin mek. So yu dɔktɔ kin pe atɛnshɔn to di sayn dɛn we yu gɛt.
So, na sɔm tin dɛn we de sho se dɛn de du risach we gɛt ay kwaliti ɛn we pɔsin kin abop pan:
- Rigyuletɔri aprɔval: Nyu drɔgs, vaysin, ɛn mɛrɛsin divays dɛn fɔ gɛt aprɔval frɔm ɛjɛnshi lɛk FDA na Amɛrika. Dɛn ɛjɛnshi ya gɛt strɔng lɔ dɛn fɔ protɛkt pipul dɛn we de tek pat pan risach.
- Indipɛndɛnt rivyu: Na wan tim we gɛt dɔktɔ ɔ sayɛnsman dɛn we nɔ de pan di risach kin rivyu di risach ɔltɛm. Dɛn de mek shɔ se i sef fɔ di wan dɛn we de tek pat ɔl di tɛm we dɛn de du di wok.
- Infɔm Kɔnsɛnt : I impɔtant fɔ mek dɛn gɛt infɔm kɔnsɛnt frɔm ɔlman we tek pat pan di risach. Dis min se bifo pɔsin sayn fɔ tek pat, dɛn fɔ ɛksplen am klia wan ɔl di bɛnifit dɛn, di bad tin dɛn we i kin du, ɛn di prɔblɛm dɛn we i kin gɛt, ɛn gi am ɔl di infɔmeshɔn we i nid fɔ mek i disayd fɔ du sɔntin we i no.
Mɛsej we dɛn kin kɛr go na os
- Ɛvri mɛrɛsin ɛn tritmɛnt we yu de yuz, dɛn dɔn du mɛdikal risach fɔ mek shɔ se i sef ɛn i go wok bifo i rich na yu an.
- Dɛn stɔdi ya kin tek sɔm ia, ɛn strikt lɔ ɛn step dɛn de fɔ mek shɔ se di wan dɛn we tek pat sef.
- Fɔ tek pat pan risach na tin we pɔsin kin du ɔltɛm, ɛn indipɛndɛnt kɔmiti dɛn kin wach yu sef ɔltɛm.
- We yu dɔktɔ gi yu nyu mɛrɛsin, dat kin bi bay pruf frɔm ay kwaliti risach lɛk dis.
Mɛdikal risach, klinik trial, mɛdikal stɔdi, plasɛbo, drɔg risach, klinik trial
💬 Comments (0)
No kɔmɛnt nɔ de yet. Ad yu kɔmɛnt ya fɔ di fɔs tɛm.
Ad yu kɔmɛnt